Suppr超能文献

克服双特异性异二聚体 IgG 抗体中链关联问题的进展。

Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies.

机构信息

Discovery Oncology, Roche Pharma Research and Early Development pRED, Roche Glycart AG, Schlieren, Switzerland.

出版信息

MAbs. 2012 Nov-Dec;4(6):653-63. doi: 10.4161/mabs.21379. Epub 2012 Aug 27.

Abstract

The development of bispecific antibodies has attracted substantial interest, and many different formats have been described. Those specifically containing an Fc part are mostly tetravalent, such as stabilized IgG-scFv fusions or dual-variable domain (DVD) IgGs. However, although they exhibit IgG-like properties and technical developability, these formats differ in size and geometry from classical IgG antibodies. Thus, considerable efforts focus on bispecific heterodimeric IgG antibodies that more closely mimic natural IgG molecules. The inherent chain association problem encountered when producing bispecific heterodimeric IgG antibodies can be overcome by several methods. While technologies like knobs-into-holes (KiH) combined with a common light chain or the CrossMab technology enforce the correct chain association, other approaches, e.g., the dual-acting Fab (DAF) IgGs, do not rely on a heterodimeric Fc part. This review discusses the state of the art in bispecific heterodimeric IgG antibodies, with an emphasis on recent progress.

摘要

双特异性抗体的开发引起了广泛关注,已经描述了许多不同的形式。那些特别含有 Fc 部分的抗体大多是四价的,例如稳定化的 IgG-scFv 融合物或双可变结构域 (DVD) IgG。然而,尽管这些抗体具有 IgG 样性质和技术可开发性,但它们在大小和几何形状上与经典 IgG 抗体不同。因此,人们投入了相当大的精力来研究更能模拟天然 IgG 分子的双特异性异二聚体 IgG 抗体。在生产双特异性异二聚体 IgG 抗体时遇到的固有链缔合问题可以通过几种方法来克服。虽然像 Knobs-into-holes (KiH) 与通用轻链结合或 CrossMab 技术这样的技术可以强制正确的链缔合,但其他方法,例如双作用 Fab (DAF) IgG,则不依赖于异二聚体 Fc 部分。本文讨论了双特异性异二聚体 IgG 抗体的最新技术进展,重点介绍了最近的进展。

相似文献

8
Engineering bispecific antibodies with defined chain pairing.工程化具有确定链配对的双特异性抗体。
N Biotechnol. 2017 Oct 25;39(Pt B):167-173. doi: 10.1016/j.nbt.2016.12.010. Epub 2017 Jan 27.

引用本文的文献

3
Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer.癌症中靶向PD-1/PD-L1的多特异性抗体
BioDrugs. 2025 May;39(3):427-444. doi: 10.1007/s40259-025-00712-6. Epub 2025 Mar 19.
6
DARPin-fused T cell engager for adenovirus-mediated cancer therapy.用于腺病毒介导癌症治疗的串联亲和素融合型T细胞衔接器
Mol Ther Oncol. 2024 May 29;32(3):200821. doi: 10.1016/j.omton.2024.200821. eCollection 2024 Sep 19.

本文引用的文献

3
Enhanced HIV-1 neutralization by antibody heteroligation.抗体异连接增强对 HIV-1 的中和作用。
Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):875-80. doi: 10.1073/pnas.1120059109. Epub 2012 Jan 4.
6
Role of MetMAb (OA-5D5) in c-MET active lung malignancies.MetMAb(OA-5D5)在 c-MET 阳性肺恶性肿瘤中的作用。
Expert Opin Biol Ther. 2011 Dec;11(12):1655-62. doi: 10.1517/14712598.2011.626762.
8
Buy buy bispecific antibodies.买买双特异性抗体。
Nat Rev Drug Discov. 2011 Oct 31;10(11):798-800. doi: 10.1038/nrd3581.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验